21 October 2021 - BEAM Alliance

How the EU Pharmaceutical Strategy could help prevent the next pandemic

Video recordings of BEAM’s Roundtable. Discussion with EC officials and experts on the AMR initiatives of the EU Pharmaceutical Strategy.

27 September 2021 - BEAM Alliance

BEAM Alliance wants HERA to effectively support R&D in antimicrobial resistance

BEAM Alliance welcomes the HERA proposal but urges EU Member States to recognise the importance of early-stage support for Research…

17 November 2021 - BEAM Alliance

20 research, medical and pharmaceutical organizations call on G7 to step up action against antibiotic resistance

20 national and international organisations from academia, healthcare, global health and the pharmaceutical industry appealed today to G7 governments to…

24 November 2021 - BEAM Alliance

AMR: The life of innovative SMEs

WAAW 2021. We take you behind the scenes. This series of comics illustrates the life of SMEs innovating in the…

31 January 2022 - BEAM Alliance

Towards a functioning AMR market: 4 pillars for a PULL incentive in Europe

In its latest position paper, BEAM Alliance proposes 4 pillars to design an efficient PULL incentive for AMR in Europe.

24 October 2022 - Event

BIO-EUROPE 2022: FACILITATING GLOBAL PARTNERSHIPS THAT DRIVE LIFE SCIENCE DEALMAKING

BIO-Europe® is the preeminent partnering conference for the life sciences, bringing together international decision makers from the biotechnology, pharmaceutical and…

BEAM News
Member News
Events

Latest news of BEAM Alliance

31 January 2022 - BEAM Alliance

Towards a functioning AMR market: 4 pillars for a PULL incentive in Europe

In its latest position paper, BEAM Alliance proposes 4 pillars to design an efficient PULL incentive for AMR in Europe.

25 November 2021 - BEAM Alliance

Antimicrobial Resistance Campaign 2021

Antimicrobial Resistance Campaign 2021. The needs of SMEs must be considered when reshaping the regulatory framework in AMR innovation.

24 November 2021 - BEAM Alliance

AMR: The life of innovative SMEs

WAAW 2021. We take you behind the scenes. This series of comics illustrates the life of SMEs innovating in the…

17 November 2021 - BEAM Alliance

20 research, medical and pharmaceutical organizations call on G7 to step up action against antibiotic resistance

20 national and international organisations from academia, healthcare, global health and the pharmaceutical industry appealed today to G7 governments to…

21 October 2021 - BEAM Alliance

How the EU Pharmaceutical Strategy could help prevent the next pandemic

Video recordings of BEAM’s Roundtable. Discussion with EC officials and experts on the AMR initiatives of the EU Pharmaceutical Strategy.

27 September 2021 - BEAM Alliance

BEAM Alliance wants HERA to effectively support R&D in antimicrobial resistance

BEAM Alliance welcomes the HERA proposal but urges EU Member States to recognise the importance of early-stage support for Research…

page 1/5

Tweets by alliancebeam

View twitter feed

Latest news of BEAM Members

16 May 2022 - DEINOVE

DEINOVE reaches the first milestones of the Boost-ID project, selected as part of the France Relance plan, with the operational installation of its microfluidic screening platform

The new therapies discovered and developed by DEINOVE target superbugs (microbes that have become resistant to one or more antimicrobials)…

12 May 2022 - Destiny Pharma plc

Destiny Pharma plc: World leading C. difficile scientists to present landmark data on the ability of NTCD-M3 to colonise the gut after antibiotic administration

NTCD-M3 is a novel microbiome therapeutic being developed to reduce the recurrence of C. difficile infections in the gut. CDI…

02 May 2022 - BioVersys AG

BioVersys successfully completes three Phase I clinical trials of BV100

We are pleased by the favorable safety of BV100 at the doses studied in our clinical trials. This positive data…

21 April 2022 - NovaBiotics Ltd

NovaBiotics Announces Presentations of New Data for NM002 and NP339 at the European Congress of Clinical Microbiology & Infectious Diseases

NovaBiotics Ltd is a privately held, clinical-stage biotechnology company revolutionizing the treatment of medically unmet, life-threatening and life-limiting diseases with…

12 April 2022 - Infex Therapeutics Ltd

Infex welcomes NICE and NHS England’s new antibiotic reimbursement mechanism

For Infex, this news comes at an exciting time as our RESP-X and MET-X AMR programs are set to start…

11 April 2022 - Nabriva Therapeutics GmbH

Nabriva Therapeutics Announces First Patient Enrolled in Phase 1 Trial of XENLETA® (lefamulin) in Adult Patients with Cystic Fibrosis

XENLETA (lefamulin) is a first-in-class semi-synthetic pleuromutilin antibiotic for systemic administration in humans discovered and developed by the Nabriva Therapeutics…

page 1/38

Events

24 October 2022

BIO-EUROPE 2022: FACILITATING GLOBAL PARTNERSHIPS THAT DRIVE LIFE SCIENCE DEALMAKING

BIO-Europe® is the preeminent partnering conference for the life sciences, bringing together international decision makers from the biotechnology, pharmaceutical and…

15 October 2022

6th International Course on Antibiotics and Resistance (ICARe)

The emergence and spread of bacteria resistant to many drug classes seriously threaten all branches of modern medicine. There is…

07 April 2022

6th AMR Conference

The AMR conference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and…

28 March 2022

BIO-Europe Spring 2022: 16th Annual International Partnering Conference: a 100% digital event.

The sixteenth annual BIO-Europe Spring® conference will bring together the life science community for global dealmaking in-person and digitally.

14 February 2022

4th Bacteriophage Therapy Summit

The definitive gathering of global phage experts across disciplines and industries is back. Focusing on human health and disease, advance…

26 January 2022

Human – Animal One Health: At the Confluence of human & veterinary public health

«The One Health Concept: At the confluence of human and veterinary public health» aims to bring together researchers, industrial stakeholders and…

26 January 2022

REVIVE Webinar: New technologies and strategies to overcome the challenges of sexually transmitted infections

REVIVE is a space for everybody with an interest in antimicrobial R&D.

19 January 2022

REVIVE Webinar: Target candidate profiles and target product profiles for new antimicrobials

REVIVE is a space for everybody with an interest in antimicrobial R&D.

10 January 2022

Biotech Showcase 2022 (In-person & Virtual Event)

Engage with Global investors & Life Sciences Executives! Join us from January 10–12, 2022 in San Francisco, or Join us…

page 1/13